Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, audio call recording of the earnings call held on 31st January 2022 at 5.00 p.m. has been uploaded on the Company's website and can be accessed through the link: http://www.ajantapharma.com/AdminData/Results/EarningsCallAudioQ3(Oct-Dec)2021-22.mp3
Further to our communication dated 29th October 2021 on earnings call, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, written transcript of the earnings call held on 29th October 2021 at 4.45 p.m. has been uploaded on the Company's website and can be accessed through the link http://www.ajantapharma.com/AdminData/Results/EarningsCallTranscriptQ2(Jul-Sep)2021-22.pdf
Further to our communication dated 29th October 2021 on earnings call, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, written transcript of the earnings call held on 29th October 2021 at 4.45 p.m. has been uploaded on the Company's website and can be accessed through the link http://www.ajantapharma.com/AdminData/Results/EarningsCallTranscriptQ2(Jul-Sep)2021-22.pdf
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, audio call recording of the earnings call held on 29th October 2021 at 4.45 p.m. has been uploaded on the Company's website and can be accessed through the link: http://www.ajantapharma.com/AdminData/Results/EarningsCallAudioQ2(Jul-Sep)2021-22.mp3 This is for your information and records please.
Further to our communication dated 30th July 2021 on earnings call, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, written transcript of the earnings call held on 29th July 2021 at 5.30 p.m. has been uploaded on the Company's website and can be accessed through the link: http://www.ajantapharma.com/AdminData/Results/EarningsCallTranscriptQ1(Apr-Jun)2021-22.pdf This is for your information and records please.
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, audio call recording of the earnings call held on 29th July 2021 at 5.30 p.m. has been uploaded on the Company's website and can be accessed through the link: http://www.ajantapharma.com/AdminData/Results/EarningsCallAudioQ1(Apr-Jun)2021-22.mp3 Written transcript of the same will be submitted in due course.
Pursuant to Regulation 30 of the SEBI (Listing obligations and Disclosure Requirements ) Regulations 2015, we are enclosing herewith the schedule of Earnings conference call to be held on 29th July 2021, post Board meeting. This is for your information and records please.
Further to our communication dated 30th April 2021 on earnings call, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, written transcript of the earnings call held on 30th April 2021 at 5.30 p.m. has been uploaded on the Company's website and can be accessed through the link http://ajantapharma.com/Results.aspx This is for your information and records please.
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, audio call recording of the earnings call held on 30th April 2021 at 5.30 p.m. has been uploaded on the Company's website and can be accessed through the link http://ajantapharma.com/Results.aspx Written transcript of the same will be submitted in due course. This is for your information and records please.
